drugset / Trial / NCT01895400
Effect of Renexin Tablet in Patients With Recurrent Vestibulopathy
Phase 3
Terminated
26 enrolled
Jong Woo Chung
Asan Medical Center · collabSK Chemicals Co., Ltd. · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether Renexin is effective in the treatment of vestibular symptoms in patients with recurrent vestibulopathy.
Timeline
- Start
- 2013-07
- Primary completion
- 2015-12
- Completion
- 2015-12
Outcome
Outcome not reported
Stopped (Enrollment): “Participant enrollment is much delayed. The whole design needs to be revised.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Cilostazol | Small molecule | 100 mg | Oral |
| Comparator | gingko biloba extract | Unknown | 80 mg | Oral |